| Alexis Witt, PT, DPT | |
|
401 N 9th St, Bismarck, ND 58501-4530 | |
| (701) 712-4500 | |
| (701) 712-4011 |
| Full Name | Alexis Witt |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 401 N 9th St, Bismarck, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033515788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1629 (North Dakota) | Primary |
| Provider Name | Mid Dakota Clinic, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275587826 PECOS PAC ID: 9638072895 Enrollment ID: O20040127001063 |
News Archive
Covidien plc today announced the expansion of its Sonicision Cordless Ultrasonic Dissection Device portfolio, following U.S. Food and Drug Administration 510(k) clearance of three additional device lengths: 13 cm, 26 cm, and 48 cm.
The largest ever study of smoking in the Asia Pacific Region, and one of the largest smoking studies ever conducted anywhere in the world, has dispelled a long-held myth that smokers in Asian populations are less susceptible than Western populations to the risks of smoking, such as coronary heart disease and stroke.
VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."
BioMimetic Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled an Orthopedic and Rehabilitation Devices Panel meeting on May 12, 2011 to review the Company's Premarket Approval (PMA) application for Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S.
Providing patients with chronic heart failure access to remote monitoring, for example by telephone or telemonitoring using wireless technology, reduces deaths and hospitalisations and may provide benefits on health care costs and quality of life. These are the conclusions of a new Cochrane Systematic Review by an international team of researchers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexis Witt, PT, DPT 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 712-4500 | Alexis Witt, PT, DPT 401 N 9th St, Bismarck, ND 58501-4530 Ph: (701) 712-4500 |
News Archive
Covidien plc today announced the expansion of its Sonicision Cordless Ultrasonic Dissection Device portfolio, following U.S. Food and Drug Administration 510(k) clearance of three additional device lengths: 13 cm, 26 cm, and 48 cm.
The largest ever study of smoking in the Asia Pacific Region, and one of the largest smoking studies ever conducted anywhere in the world, has dispelled a long-held myth that smokers in Asian populations are less susceptible than Western populations to the risks of smoking, such as coronary heart disease and stroke.
VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."
BioMimetic Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled an Orthopedic and Rehabilitation Devices Panel meeting on May 12, 2011 to review the Company's Premarket Approval (PMA) application for Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S.
Providing patients with chronic heart failure access to remote monitoring, for example by telephone or telemonitoring using wireless technology, reduces deaths and hospitalisations and may provide benefits on health care costs and quality of life. These are the conclusions of a new Cochrane Systematic Review by an international team of researchers.
› Verified 8 days ago
Ashley Russell, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 207 W Front Ave, Bismarck, ND 58504 Phone: 701-751-0994 | |
Jonathan Jay Fischer, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2945 N 11th St, Bismarck, ND 58503 Phone: 701-258-7730 Fax: 701-258-7803 | |
Mrs. Kari Lynn Harris, DPT, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 225 N 7th St, Bismarck, ND 58501 Phone: 701-323-6837 Fax: 701-323-6907 | |
Andrew Johnson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1000 Tacoma Ave Ste 500, Bismarck, ND 58504 Phone: 701-751-3001 | |
Jennifer Voigt, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 | |
Anna Wolf, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4580 Coleman St, Bismarck, ND 58503 Phone: 701-751-5118 |